期刊文献+

靶向端粒酶调节相关基因TRAP siRNA表达载体的构建 被引量:3

Construction of Expressing Vector of siRNA Targeting Telomeras Regulation-associated Protein (TRAP) Gene
下载PDF
导出
摘要 目的构建靶向端粒酶调节相关基因TRAP的siRNA表达载体。方法根据siRNA设计原则,设计并化学合成2段编码短发夹RNA序列、靶向端粒酶调节相关基因TRAP的寡核苷酸,各64个碱基,退火,克隆到线性化的pSilencerTM21u6neo质粒U6启动子下游重组构建RNAi质粒。结果重组质粒pSilencerTM21u6neoTRAP经过插入片段基因序列分析,结果表明64个碱基成功插入到预定位子,并且序列完全一致。结论成功构建靶向TRAP基因的siRNA表达载体,为进一步研究TRAP在调控hTERT的表达、降低端粒酶活性和肿瘤的基因治疗方面的作用做了基础。 Objective: To construct expression vector of siRNA targeting telomeras regulation-associated protein gene. Methods: Each 64 base-pair oligonucleotide for hairpin RNA expression which targeted telomeras regulation-associated protein gene was designed and chemical synthesized. After annealing, oligonucleotides were inserted into the downstream of U6 promoter of pSilencer^TM 2.1-u6 neo. Result: Recombinant pSilencer^TM 2.1-u6 neo-TRAP vector was confirmed by sequencing analysis with M13F primer,the results demonstrated that 64bp had been inserted the expected site. Furthermore, the inserted sequence was exactly correct. Conclusion:pSilencer^TM 2.1-u6 neo-TRAP has been constructed successfully.This will be a base for the study of its function in regulating hTERT, to reduce telomerase activity and in gene treatment of tumor. [
出处 《江苏大学学报(医学版)》 CAS 2004年第416期476-478,共3页 Journal of Jiangsu University:Medicine Edition
关键词 端粒酶调节相关基因 基因表达 RNA干扰 Gene, telomeras regulation-associated protein(TRAP) Gene expression RNA interference (RNAi)
  • 相关文献

参考文献7

  • 1Hahn WC.Targeting with telomerase [J].Clin Cancer Res,2004,10(4):1203-1205.
  • 2Patrick J, Paddison, Amy A,et al.Stable suppression of gene expression by RNAi in mammalian cells [J]. PNAS, 2002, 99: 1443-1448.
  • 3siRNA design,http://www.ambion.com/techlib/misc/siRNA-design.html.
  • 4Brum melkamp TR,Bernards R,Agami R.Stable suppression of tumorigenicity by virus-mediated RNA interference[J].Cancer Cell,2002,2(3):234-247.
  • 5Scherr M,Battmer K,Winkler T,et al.Specific inhibition of bcr-abl gene expression by small interfering RNA[J]. Blood,2003,101(4):1566-1569.
  • 6Feng J,Funk WP,Wang SS,et al.The RNA compoment of human telomerase [J].Science,1995,269(5208):1236.
  • 7Kosciolek BA, Kalantidis K, Tabler M, et al. Inhibition of telomerase activity in human cancer cells by RNA interference [J]. Molecular Cancer Therapeutics, 2003, 2(3):209-216.

同被引文献22

  • 1闫歌,黄爱龙.RNA干扰及其在肿瘤研究中的应用进展[J].国外医学(肿瘤学分册),2003,30(6):409-411. 被引量:3
  • 2雷印胜,张海洲,王来城,郭兰敏,范全心,邹承伟,李红昕,王安彪.串联表达大鼠心肌细胞Kir2·1shRNA载体的构建及其体外效应[J].中华医学杂志,2005,85(41):2910-2915. 被引量:10
  • 3卓文磊,王彦,张璟.针对CTGF的shRNA抑制TGFβ1诱导人肾小管上皮细胞合成胶原[J].中国现代医学杂志,2006,16(7):981-984. 被引量:13
  • 4刘明社,王兰,赵中夫,张国英,张芸,封江南.干扰Fas受体表达的串联shRNA表达载体的构建[J].世界华人消化杂志,2006,14(22):2174-2179. 被引量:6
  • 5Qian X, Cheng J, Chen A, et al. Long-term effects of short hairpin RNA-targeted human telomerase reverse transcriptase on suppression of SGC-7901 cell proliferation by inhibition of telomerase activity[J]. Oncol Rep, 2008,19 (2) : 575-581.
  • 6Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells[J]. Nature, 2001,411 (6836) : 494-498.
  • 7Ji J, Wernli M, Klimkait T, et al. Enhanced gene silencing by the application of mutiple specific small mterferemg RNAs[J]. FEBS Lett, 2003,552 (2-3) : 247-252.
  • 8Zou L, Zhang P, Luo C, et al. ShRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity[J]. Cancer Chemother Pharmacol, 2006,57 (3):328-334.
  • 9DOME JS, LOOK AT. Three molecular determinants of malignant conversion and their potential as therapeutic targets[J]. Curt Opin Oncol. 1999, 11: 58.
  • 10KIRKPATRICK KL, MOKBEL K. The significance of human telomerase reverse transcriptase (hTERT) in cancer[J]. EurJ Surg Oncol, 2001, 27: 754-760.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部